Ftse Mib
34.816,78
-1,64%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
69.753,27
5,25%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ DermTech Inc (DMTK) DermTech Inc (DMTK) Notizie

DMTK

DermTech (DMTK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DMTK
DataOraFonteTitoloSimboloCompagnia
17/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMTKDermTech Inc
14/05/202422:05Business WireDermTech Reports First-Quarter 2024 Financial ResultsNASDAQ:DMTKDermTech Inc
18/04/202422:15Business WireDermTech to Explore Strategic Alternatives and Implement Restructuring PlanNASDAQ:DMTKDermTech Inc
01/04/202422:05Business WireDermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMTKDermTech Inc
08/03/202414:05Business WireDermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative DermatologyNASDAQ:DMTKDermTech Inc
08/03/202402:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMTKDermTech Inc
07/03/202422:17Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DMTKDermTech Inc
29/02/202422:53Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DMTKDermTech Inc
29/02/202422:01Business WireDermTech Reports Fourth-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
13/02/202414:05Business WireDermTech Announces Release Date for Fourth-quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
31/01/202422:30Business WireDermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline OperationsNASDAQ:DMTKDermTech Inc
18/01/202414:05Business WireDermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin TypesNASDAQ:DMTKDermTech Inc
16/01/202414:05Business WireDermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on AssayNASDAQ:DMTKDermTech Inc
08/01/202414:00Business WireDermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
04/12/202311:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK)NASDAQ:DMTKDermTech Inc
02/11/202321:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DMTKDermTech Inc
02/11/202321:01Business WireDermTech Reports Third-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
12/10/202314:05Business WireDermTech Announces Release Date for Third-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
23/09/202302:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMTKDermTech Inc
21/09/202322:05Business WireDermTech Grants New CCO Mark Aguillard Inducement Award Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:DMTKDermTech Inc
19/09/202314:05Business WireDermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
11/09/202314:05Business WireDermTech Appoints Mark Aguillard as Chief Commercial OfficerNASDAQ:DMTKDermTech Inc
12/08/202300:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DMTKDermTech Inc
03/08/202322:01Business WireDermTech Reports Second-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
19/07/202314:00Business WireDermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
17/07/202314:00Business WireDermTech Announces Release Date for Second-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
13/07/202322:09Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:DMTKDermTech Inc
12/07/202314:00Business WireDermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
28/06/202322:30Business WireDermTech Announces Restructuring to Prioritize Growth Opportunities and Streamline OperationsNASDAQ:DMTKDermTech Inc
14/06/202314:00Business WireECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DMTK

La tua Cronologia

HITB
BANCAUSD
Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network